
Tingting Zhang
@Chaosdyna
Followers
454
Following
6K
Media
183
Statuses
3K
A patient advocate and weaver of tech-enabled clinical research network. ASCOBT2019 awardee for mobile deployed care in Asia. FCOI https://t.co/ANJVkaY0oP
Joined February 2011
RT @Erman_Akkus: 📙Long-term surveillance recommendations for young adult cancer survivors.@myESMO . ✅An excellent review and invaluable res….
0
24
0
RT @oncodaily: 📢25 Posts Not To Miss From MASCC 2025. @CancerCareMASCC .@iankleckner | @DarcyBurbage | @stage4kelly | @coffeemommy | @Dr_Ra….
0
12
0
RT @oncodaily: Thrilled to Share Insights from @CancerCareMASCC 2025 - @DurstonVicki . #OncoDaily #Oncology #Cance….
0
1
0
RT @oncodaily: Immersive and Inspiring MASCC Meeting in Seattle - Maryam Lustberg.@maryam_lustberg @CancerCareMASCC . .
0
1
0
RT @oncodaily: The Group Shot of Presenters and Panelists in MASCC 2025 - Tingting Zhang (@Chaosdyna).@CancerCareMASCC . .
0
1
0
RT @Liz_ORiordan: The terrifying rise of alternative cancer coaches - and the nonsense they told me to do to cure my cancer . In today’s @M….
0
109
0
RT @cancer_nurses: 📅 As National Cancer Survivors Month continues, don't miss the second part of our survivorship-focused series with @Darc….
0
1
0
RT @DarcyBurbage: One reason I love #MASCC25 the innovative & diverse research!.#AdamDaly shared powerful qualitative work on therapeutic t….
0
1
0
RT @DarcyBurbage: Thank you to the #MASCC25 Conference Planning Committee & @CancerCareMASCC Staff & Board for a fabulous 3 days of learnin….
0
5
0
Example given on Sentinel: BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High–Neutropenia Risk Chemotherapy published 2021. They have more data now to answer patient groups’ concerns @stage4kelly
0
0
10
RT @stage4kelly: Even with data on benefit of prophylaxis only half of people in DB04 got prophylaxis. And again, there is delayed onset -….
0
2
0
RT @JunMaoMD: Our RCT should virtual integrative medicine not only improved symptoms of fatigue & depression but also reduced patients’ ris….
0
3
0
Taking photo from Vicki Durston from BCNA - the group shot for presenters and panelists in #MASCC25 parallel session from patient partners on common and uncommon toxicities.
1
3
18
RT @stage4kelly: In a @DaiichiSankyoUS sponsored session @maryam_lustberg talks about management of ADC related 🤢 (hint, it ain’t one drug)….
0
3
0
RT @stage4kelly: Diarrhea 🏃 🚽 💩 is another big problem. Unfortunately most of the treatment options have their own side effects needing add….
0
1
0
RT @dquin_ng: Helpful self-management strategies for nausea & vomiting during cancer treatment. Shared by @maryam_lustberg at #mascc25. htt….
0
1
0
#MASCC25 patient partners united discussing common and uncommon toxicities at a session chaired by @maryam_lustberg @MammaMiaMagazin
1
1
11